Legal Representation
Attorney
Brent D. Sokol
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 6, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Feb 6, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Oct 10, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 10, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 10, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 18, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 15, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 4, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Business research and data analysis in the field of pharmaceutical drug development and/or diagnostics development, namely, selecting and analyzing patient data and genetic information to assist with predicting, measuring, or evaluating the performance of pharmaceuticals in the field of pharmaceutical drug development and diagnostics development (including companion diagnostics development and complementary diagnostics development)
Additional Information
Pseudo Mark
MIRADOR THREE HUNDRED SIXTY
Pseudo Mark
MIRADOR THREE SIX ZERO
Pseudo Mark
MIRADOR THREE SIXTY
Classification
International Classes
035